Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
Provided By GlobeNewswire
Last update: Aug 14, 2025
Announced CNSide® CSF assay platform launch timeline
Initiated the REYOBIQ dose optimization trial for patients with leptomeningeal metastases
Read more at globenewswire.com
